These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 28062563)

  • 21. How neuroinflammation contributes to neurodegeneration.
    Ransohoff RM
    Science; 2016 Aug; 353(6301):777-83. PubMed ID: 27540165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Concepts of Mixed Pathologies in Neurodegenerative Diseases.
    Forrest SL; Kovacs GG
    Can J Neurol Sci; 2023 May; 50(3):329-345. PubMed ID: 35356856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein astrogliopathies in human neurodegenerative diseases and aging.
    Kovacs GG; Lee VM; Trojanowski JQ
    Brain Pathol; 2017 Sep; 27(5):675-690. PubMed ID: 28805003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nervous yeast: modeling neurotoxic cell death.
    Braun RJ; Büttner S; Ring J; Kroemer G; Madeo F
    Trends Biochem Sci; 2010 Mar; 35(3):135-44. PubMed ID: 19926288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal network disintegration: common pathways linking neurodegenerative diseases.
    Ahmed RM; Devenney EM; Irish M; Ittner A; Naismith S; Ittner LM; Rohrer JD; Halliday GM; Eisen A; Hodges JR; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1234-1241. PubMed ID: 27172939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurodegenerative disorders: review of current classification and diagnostic neuropathological criteria].
    Matej R; Rusina R
    Cesk Patol; 2012 Apr; 48(2):83-90. PubMed ID: 22716055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
    Kwong LK; Uryu K; Trojanowski JQ; Lee VM
    Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are comorbidities compatible with a molecular pathological classification of neurodegenerative diseases?
    Kovacs GG
    Curr Opin Neurol; 2019 Apr; 32(2):279-291. PubMed ID: 30672825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.
    Kovacs GG
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spreading of pathology in neurodegenerative diseases: a focus on human studies.
    Brettschneider J; Del Tredici K; Lee VM; Trojanowski JQ
    Nat Rev Neurosci; 2015 Feb; 16(2):109-20. PubMed ID: 25588378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
    Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-synuclein and tau: teammates in neurodegeneration?
    Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ
    Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology.
    Yang H; Hu HY
    FEBS J; 2016 Oct; 283(20):3705-3717. PubMed ID: 27016044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain.
    Wakabayashi K; Mori F; Tanji K; Orimo S; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):1-12. PubMed ID: 20532896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis.
    Boeve BF
    Alzheimer Dis Assoc Disord; 2007; 21(4):S31-8. PubMed ID: 18090421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prion model for progression and diversity of neurodegenerative diseases.
    Stopschinski BE; Diamond MI
    Lancet Neurol; 2017 Apr; 16(4):323-332. PubMed ID: 28238712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.